Less venture-money for zealous companies
The amount of Danish venture capital for the life science business decreased significantly in 2011 in spite of a great increase in the number of applications from financially starved companies. The question remains if the moderate optimism for 2012 will manage to hold the fort.
af LEONORA BECK
Even though venture capital companies received a higher number of applications in 2011, the total investment figure of DKK 1.3 billion was down 16 % compared with 2010.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
